Compare Starbucks Corp (SBUX) vs Viatris Inc (VTRS) Price & Performance

Starbucks (SBUX) trades at $93.21, down 0.4% with bearish technical signals. Recent earnings show mixed results with Q2 2026 beating expectations but Q4 2025 missing. The company is undergoing strategic restructuring with 250 store closures announced in September 2026, while maintaining dividend payments. Revenue growth remains modest at $37.18B for 2025 with net income margin at 5.17%. Analyst consensus remains positive with a $115.50 price target despite current bearish technical indicators.

SBUX presents a turnaround opportunity with strong analyst support but faces execution risks from store closures and competitive pressures. The stock trades at premium valuations (P/E 53.88) requiring sustained earnings growth. Near-term volatility expected during restructuring, while long-term prospects depend on successful portfolio optimization and international expansion, particularly in Asian markets.

Viatris (VTRS) trades at $17.44, down 0.29% on the day, with a bullish technical outlook supported by moving averages and oversold RSI levels. The company has beaten earnings estimates for three consecutive quarters, though it faces profitability challenges with negative net margins. Recent positive developments include FDA approval for WAKIX in Japan and consistent dividend payments, while analyst consensus leans toward a buy rating with a $22.17 price target representing 27% upside potential.

The stock presents a value opportunity with reasonable P/S and P/B ratios, but investors must weigh strong cash generation against persistent profitability issues. Key catalysts include continued earnings beats and pipeline progress, while risks involve margin pressure and high debt levels. The current valuation disconnect between technical strength and fundamental challenges creates a balanced risk-reward profile for patient investors.